Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias
- 1 November 1995
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 23 (11), 1816-1824
- https://doi.org/10.1097/00003246-199511000-00005
Abstract
OBJECTIVE: To compare the efficacy of parenteral magnesium sulfate vs. amiodarone in the therapy of atrial tachyarrhythmias in critically ill patients. DESIGN: Prospective, randomized study. SETTING: Multidisciplinary intensive care unit (ICU) at a university teaching hospital. PATIENTS: Forty-two patients, 21 medical and 21 surgical, of mean (SD) age 67 +/- 15 yrs and mean Acute Physiology and Chronic Health Evaluation II score of 22 +/- 6, with atrial tachyarrhythmias (ventricular response rate of > or = 120 beats/min) sustained for > or = 1 hr. INTERVENTIONS: After correction of the plasma potassium concentration to > or = 4.0 mmol/L, patients were randomly allocated to treatment with either a) magnesium sulfate 0.037 g/kg (37 mg/kg) bolus followed by 0.025 g/kg/hr (25 mg/kg/hr); or b) amiodarone 5 mg/kg bolus and 10 mg/kg/24-hr infusion. Therapeutic plasma magnesium concentration in the magnesium sulfate group was 1.4 to 2.0 mmol/L. Therapeutic end point was conversion to sinus rhythm over 24 hrs. MEASUREMENTS AND MAIN RESULTS: At study entry (time 0), initial mean ventricular response rate and systolic blood pressure were 151 +/- 16 (SD) beats/min and 127 +/- 30 mm Hg in the magnesium sulfate group vs. 153 +/- 23 beats/min and 123 +/- 23 mm Hg in the amiodarone group, respectively (p = .8 and .65). Plasma magnesium (time 0) was 0.84 +/- 0.20 vs. 1.02 +/- 0.22 mmol/L in the magnesium and amiodarone group, respectively (p = .1). Eight patients had chronic dysrhythmias (magnesium 3, amiodarone 5). Excluding the two patient deaths (amiodarone group, time 0 + 12 to 24 hrs), no significant change in systolic blood pressure subsequently occurred in either group. In the magnesium group, mean plasma magnesium concentrations were 1.48 +/- 0.36, 1.82 +/- 0.41, 2.16 +/- 0.45, and 1.92 +/- 0.49 mmol/L at time 0 + 1, 4, 12 and 24 hrs, respectively. By logistic regression, the probability of conversion to sinus rhythm was significantly better for magnesium than for amiodarone at time 0 + 4 (0.6 vs. 0.44), 12 (0.72 vs. 0.5), and 24 (0.78 vs. 0.5) hrs. In patients not converting to sinus rhythm, a significant decrease in ventricular response rate occurred at time 0 + to 0.5 hrs (mean decrease 19 beats/min, p = .0001), but there was no specific treatment effect between the magnesium and the amiodarone groups; thereafter, there was no significant reduction in ventricular response rate over time in either group. CONCLUSIONS: Intravenous magnesium sulfate is superior to amiodarone in the conversion of acute atrial tachyarrhythmias, while initial slowing of ventricular response rate in nonconverters appears equally efficacious with both agents.John L. Moran, John Gallagher, Sandra L. Peake, David N. Cunningham, Mary Salagaras and Phil LepparThis publication has 29 references indexed in Scilit:
- Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodaroneIntensive Care Medicine, 1993
- Cardiac arrhythmias in critically ill patientsCritical Care Medicine, 1990
- Suppression of ventricular arrhythmias by magnesiumThe American Journal of Cardiology, 1990
- Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardiaAmerican Heart Journal, 1990
- Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusionsCritical Care Medicine, 1989
- Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery diseaseThe American Journal of Cardiology, 1989
- Effect of intravenous magnesium sulfate on supraventricular tachycardiaThe American Journal of Cardiology, 1989
- Inotropic Response to Digoxin and Dopamine in Patients with Severe Sepsis, Cardiac Failure, and Systemic HypoperfusionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1989
- Amiodarone in the Management of Cardiac Arrhythmias: Current ConceptsMedical Clinics of North America, 1988
- Magnesium and potassium therapy in multifocal atrial tachycardiaAmerican Heart Journal, 1985